Essential prescribing information format outlined in draft labeling guidance.
This article was originally published in The Gray Sheet
Executive SummaryESSENTIAL PRESCRIBING INFORMATION FORMAT OUTLINED IN FDA LABELING GUIDANCE draft dated April 15. The goal of a one-page essential prescribing information (EPI) format in device labeling is "to provide an overview and a refresher for those already familiar with the full labeling" and communicate "more effectively with practitioners and users of medical devices" the key elements in device labeling, the agency's Center for Devices and Radiological Health says in the draft guidance.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.